Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19

Background: Coronavirus disease-2019 (COVID-19) is an inflammatory, multisystem infectious disease caused by severe acute respiratory syndrome-coronavirus-2 (SARS-COV-2) and is associated with increased risk of thrombosis, particularly among critically ill patients. The myeloproliferative neoplasms...

Descripción completa

Detalles Bibliográficos
Autores principales: Leiva, Orly, Campia, Umberto, Snyder, Julia, Barns, Briana, Rizzo, Samantha, Khairani, Candrika, Al-Samkari, Hanny, Karp Leaf, Rebecca, Rosovsky, Rachel P., Goodarzi, Katayoon, Fathi, Amir T., Goldhaber, Samuel Z., Piazza, Gregory, Hobbs, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
634.Myeloproliferative Syndromes: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701645/
http://dx.doi.org/10.1182/blood-2021-151801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701645/
http://dx.doi.org/10.1182/blood-2021-151801

Ejemplares similares